$169/mo
Tirzepatide
Weekly and dual-action. Care, coaching and shipping included.
Get startedHome / Tirzepatide hair loss
Hair and GLP-1s.
Tirzepatide hair loss: why it happens, how long it lasts and what helps
Hair loss was reported in 4% to 5% of people taking Zepbound in its trials, versus 1% on placebo, mostly in women, and the label ties it to weight loss. Shedding after fast weight loss is usually temporary: dermatologists say hair tends to regain its normal fullness within 6 to 9 months. Questions? NexLife answers 24/7, and your provider can review your dose and your diet.
- 4–5% vs 1%: hair loss in the Zepbound trials
- Usually temporary: fullness returns in 6 to 9 months
- What helps: protein, key nutrients, a word with your provider
Published by NexLifeLegitScript-certifiedUpdated October 13, 2026Medically reviewed by the NexLife clinical team, led by Adam Kennah, MD (NPI 1144260043)
Hair loss in the Zepbound trials
- On tirzepatide
- 4–5%, by dose (5 to 15 mg)
- On placebo
- 1%
- Women vs men
- 7.1% vs 0.5%, on tirzepatide
- Stopped because of it
- No one on tirzepatide
Noticing more hair on your brush? Call or text (949) 818-8000. We share it with your provider.
Check my eligibility, $169/mo
4.8 out of 5 on Trustpilot · LegitScript certified
Compounded medicines aren’t FDA-approved. A NexLife provider prescribes one only if it offers a significant difference for you compared with an FDA-approved medicine.
What the trials found
How common hair loss was, and who it affected
| Group | Placebo | Tirzepatide |
|---|---|---|
| All patients | 1% | 4–5% |
| Women | 1.3% | 7.1% |
| Men | 0% | 0.5% |
“Tirzepatide” is the 5, 10 and 15 mg groups (4% to 5% by dose). Women and men from the label’s pooled analysis. These numbers come from trials of FDA-approved Zepbound. Compounded tirzepatide isn’t FDA-approved and wasn’t studied in them.
The label says hair loss was associated with weight reduction. For comparison, Wegovy’s label reports hair loss in 3.3% of people on semaglutide 2.4 mg (4% of women, 0.9% of men), versus 1% on placebo.
Why it happens
It’s usually shedding, not lasting loss
Dermatologists call it telogen effluvium: after a big stress on the body, more hairs than usual move into the resting phase and fall out together. The American Academy of Dermatology lists losing 20 pounds or more among the triggers. It’s normal to shed 50 to 100 hairs a day; with telogen effluvium, you notice much more on your brush or in the shower.
That fits what the label describes: hair loss tied to weight loss, more often in women, and no one stopping tirzepatide because of it.
The shedding timeline
What to expect, and when
Weight comes off. The change in your hair cycle starts, but you don’t see it yet.
Shedding becomes noticeable. Most people notice it a few months after the trigger, says the AAD.
Shedding slows and stops. Hair tends to regain its normal fullness within 6 to 9 months.
See a board-certified dermatologist if you’re losing hair in patches, your scalp is itchy or scaly, or heavy shedding keeps going. Other causes can look similar.
Two medications.
One flat price each.
Both are prepared by state-licensed 503A partner pharmacies and shipped free. Your provider helps you decide which one fits.
$139/mo
Semaglutide
Weekly GLP-1. Care, coaching and shipping included.
Get startedWhat’s inside every plan
- Tirzepatide: compounded, acts on two hormone pathways (GIP and GLP-1), taken once a week
- Semaglutide: compounded, acts on the GLP-1 pathway, taken once a week
- Prepared by state-licensed 503A partner pharmacies
- A licensed provider who reviews your history and follows your dose
- A personalized nutrition plan and a 1:1 coaching call
- Free expedited shipping; orders usually ship within 1 to 2 business days
- 24/7 support from real people, plus physician access during clinical hours
- HSA and FSA cards accepted, and Klarna or Afterpay at checkout
- Prefer no injections? Ask about the sublingual tablet, at its own flat price
Prescription required. Compounded medications are not FDA-approved, and a provider prescribes one only if it offers a significant difference for you compared with an FDA-approved medicine. On 12-month plans: $139 a month for tirzepatide, $119 for semaglutide, still the same at every dose. Prices checked October 7–13, 2026.
Your dose goes up.
Your price doesn’t.
No membership, no dose surcharges, no surprises. One flat, all-inclusive monthly price at every dose.
| Month one | Month two | Month three | Every month after | |
|---|---|---|---|---|
| Tirzepatide | $169 | $169 | $169 | $169 |
| Semaglutide | $139 | $139 | $139 | $139 |
Paying less somewhere else? Send us a receipt from another licensed U.S. telehealth provider and we’ll match your regular monthly price. See the terms
Month-to-month plan, all-inclusive. Longer plans cost less and stay flat. Tirzepatide is $159, $149 and $139 a month on 3-, 6- and 12-month plans. Semaglutide is $132, $125 and $119.
What would you pay with NexLife?
Tap where you are now. We’ll show your NexLife price next to it, or tell you we’ll match it.
Pick one above to see your price.
Not today?
Prices from each provider, checked October 7–13, 2026. Brand-name and compounded medications are different products; compounded medications are not FDA-approved. †Price Match Guarantee terms apply.
The NexLife Price Match Guarantee
Keep your price.
Upgrade your care.
Already on compounded tirzepatide or semaglutide? Bring your price to NexLife. If you pay less with another licensed U.S. telehealth provider, we match your regular monthly price for as long as your plan stays active.† You keep your price, and you gain a provider who follows your dose, a personal nutrition plan, a 1:1 coaching call and real people who answer 24/7.
- 1Send a receipt from the last 60 days
- 2A NexLife provider reviews your prescription
- 3Pay your matched price, at every dose
Locked while your plan is activeSame price at every doseNo membership fee
†NexLife Price Match Guarantee: for new members switching from a licensed U.S. telehealth provider with an active prescription for compounded tirzepatide or semaglutide. Send a receipt from the last 60 days and we match your regular all-in monthly price on the month-to-month plan, for the same medication (medication plus required fees; not first-month offers, sale prices, coupons or prepaid multi-month rates), for as long as your plan stays active. A NexLife provider must determine that treatment is right for you. Not open to people with Medicare, Medicaid or TRICARE coverage. Full terms.
What helps
Four things worth doing
Eat enough protein.
A practical target during GLP-1 treatment is 80 to 120 grams a day. Plan your protein.
Cover the nutrients that run low.
The 2025 joint nutrition advisory lists iron, zinc, vitamin D and B12 among nutrients to watch on GLP-1s. Ask your provider whether a multivitamin or a blood test makes sense.
Tell your provider.
They can look at your dose, how fast you’re losing weight and what you’re eating. Tell us if you’re shedding; it’s worth a conversation.
Be patient with your hair.
Shedding after weight loss usually settles on its own. Hair grows slowly, so fullness takes months to come back.
Noticing more hair on your brush?
Call or text NexLife at (949) 818-8000, 24/7. A real person answers; we share it with your provider and get back to you about next steps.
Hair loss questions
Does tirzepatide cause hair loss?
Hair loss was reported in 4% to 5% of people taking Zepbound in its trials, versus 1% on placebo. The label links it to weight reduction, and it was much more common in women (7.1%) than men (0.5%).
Is tirzepatide hair loss permanent?
Usually not. Shedding after significant weight loss is typically temporary, and hair tends to regain its normal fullness within 6 to 9 months, according to the American Academy of Dermatology.
When does hair loss start on tirzepatide?
Shedding after a trigger such as fast weight loss usually shows up a few months later, not right away.
How can I prevent hair loss on tirzepatide?
There’s no proven way to prevent it. Eating enough protein and covering nutrients that can run low on a GLP-1, like iron, zinc, vitamin D and B12, supports healthy hair. Talk to your provider before starting supplements.
Does semaglutide cause hair loss too?
Yes, in a small share of people: 3.3% on Wegovy 2.4 mg versus 1% on placebo in its trials, again more often in women.
Should I stop tirzepatide because of hair loss?
Talk with your provider first. In the Zepbound trials, no one on tirzepatide stopped because of hair loss.
Important safety information
Compounded tirzepatide and semaglutide are not FDA-approved, and the FDA hasn’t reviewed them for safety, effectiveness or quality. A provider prescribes them only when they offer a significant difference for you compared with an FDA-approved product. Both medicines may cause thyroid tumors, including cancer: don’t use either if you or a family member has had medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).
Read the full safety information
In studies with rodents, both medicines caused thyroid tumors; it isn’t known whether they cause them in people. Tell your provider if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath.
Serious side effects can include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or sulfonylureas), kidney problems from dehydration, severe stomach problems, serious allergic reactions, vision changes in people with type 2 diabetes, and a faster heart rate. Tell your care team before any surgery or procedure that uses anesthesia or deep sedation. Don’t combine either medicine with other GLP-1 medicines.
Tirzepatide can make birth control pills less effective: switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after you start and for 4 weeks after each dose increase. Both medicines may harm an unborn baby. Semaglutide should be stopped at least 2 months before a planned pregnancy. Tell your provider right away if you’re pregnant, planning to be, or breastfeeding.
This is a summary, not the complete safety information. Read the full Prescribing Information for FDA-approved tirzepatide (Zepbound) and semaglutide (Wegovy), and talk with your provider. You can report side effects to the FDA at 1-800-FDA-1088 or fda.gov/medwatch.
Who checked this page
Adam Kennah, MDMedical Director, NexLife · Board-certified in emergency medicine · NPI 1144260043
Leads the NexLife clinical team, which medically reviewed this page on October 12, 2026.
NexLife editorial teamResearch and pricing
hair loss data against the Zepbound and Wegovy labels, and the shedding facts against the American Academy of Dermatology
- Every fact, sourced. Each price and rule links to the page it comes from.
- How we make money. NexLife is a telehealth provider. We earn revenue when people join NexLife.
- Corrections, fast. See something wrong or out of date? Email care@nexlife.us and we’ll fix it.
One price at every dose
Support while you lose weight.
Compounded tirzepatide, $169 a month at every dose, with a nutrition plan and real people 24/7.
- 1Tell us about you
A short online health assessment, about 3 minutes.
- 2A licensed provider reviews it
You’re prescribed only if treatment is right for you.
- 3We ship it, then stay with you
Our partner pharmacy usually ships within 1 to 2 business days. Free shipping, 24/7 support.
Sources
- Eli Lilly and Company. Zepbound (tirzepatide) prescribing information.
- Novo Nordisk. Wegovy (semaglutide) prescribing information.
- American Academy of Dermatology. Do you have hair loss or hair shedding?.
- Obesity (Silver Spring). Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association and The Obesity Society (2025).
- NexLife. Compounded tirzepatide plans.
- U.S. Food and Drug Administration. FDA’s concerns with unapproved GLP-1 drugs used for weight loss.
- LegitScript. Certification lookup for nexlife.us.
- NexLife. Compounded semaglutide plans.